Your session is about to expire
← Back to Search
Behavioural Intervention
NAPT for Cancer Distress (NAPT Trial)
N/A
Recruiting
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 years
New (non-recurrent) head and neck cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 and 12 months
Awards & highlights
NAPT Trial Summary
This trial is testing a web app to see if it can help manage depression and distress in people who have had surgery for head and neck cancer.
Who is the study for?
This trial is for adults over 18 with new, non-recurrent head and neck cancer who have undergone surgery as their primary treatment. It's not suitable for those under 18, with recurrent cancer, previous chemo or radiation therapy, a history of psychiatric illness or psychological issues, prior cancers or known cancer distress.Check my eligibility
What is being tested?
The NAPT study tests a web-based app designed to track depression and stress in patients after head and neck cancer surgery. The goal is to see if it helps in identifying when patients need mental health services. It also looks at how well patients stick to treatments, recover functionally and return to work.See study design
What are the potential side effects?
Since the intervention involves psychosocial screening rather than medication or invasive procedures, typical medical side effects are not expected. However, participants may experience emotional discomfort while discussing personal issues during assessments.
NAPT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
My head or neck cancer is new and has not come back.
Select...
I have had surgery as my first treatment.
NAPT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 and 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 and 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Distress Thermometer Score
Secondary outcome measures
Completion of Adjuvant Therapy
Emergency Department Visits
HNRN-33
+4 moreNAPT Trial Design
2Treatment groups
Active Control
Group I: NAPT GroupActive Control1 Intervention
The NAPT Group will include adult patients undergoing primary surgical treatment for head and neck cancer. Patients will be given access to a web-based application that monitors depression, distress, and functional outcomes scores at regular intervals for 12 months. Patients will be able to alert the treatment team of decreased mood, increased distress, and functional issues impacting both. Patients will also be able to track their mood and distress levels throughout the 12 months and involve care-givers in monitoring as well.
Group II: Usual Care GroupActive Control1 Intervention
The Usual Care Group will include adult patients undergoing primary surgical treatment for head and neck cancer. Supportive care will be offered or provided according to patients' wishes.
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
889 Previous Clinical Trials
385,084 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.You have a history of mental health problems.My head or neck cancer is new and has not come back.I have had surgery as my first treatment.I have had chemotherapy or radiation therapy before.I am under 18 years old.My head or neck cancer has come back.I have had cancer or felt significant distress due to cancer before.
Research Study Groups:
This trial has the following groups:- Group 1: NAPT Group
- Group 2: Usual Care Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there availability for participants to join this clinical trial?
"Correct. According to the information present on clinicaltrials.gov, this medical trial is actively accepting patients. It was initially posted in September 1st 2017 and revised lastly on July 11th 2022; 50 individuals are being sought from one centre."
Answered by AI
What is the current enrollment quota for this experiment?
"Affirmative. Data hosted on clinicaltrials.gov provides evidence that this medical experiment, which was first uploaded to the website on September 1st 2017, is actively seeking patients. As of right now, 50 people need to be sourced from a single site."
Answered by AI
Share this study with friends
Copy Link
Messenger